Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Bayer Pharma Aktiengesellschaft
Bayer Pharma Aktiengesellschaft xfc xdf
  

Bayer Pharma Aktiengesellschaft patents

Recent patent applications related to Bayer Pharma Aktiengesellschaft. Bayer Pharma Aktiengesellschaft is listed as an Agent/Assignee. Note: Bayer Pharma Aktiengesellschaft may have other listings under different names/spellings. We're not affiliated with Bayer Pharma Aktiengesellschaft, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Pharma Aktiengesellschaft-related inventors




Date Bayer Pharma Aktiengesellschaft patents (updated weekly) - BOOKMARK this page
10/19/17 new patent  Substituted oxopyridine derivatives
10/12/17Substituted oxopyridine derivatives
10/05/17Diaminoheteroaryl substituted indazoles
10/05/17Substituted oxopyridine derivatives
09/28/17Benzyl substituted indazoles as bub1 inhibitors
09/28/17Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer
09/28/17Heteroaryl substituted indazoles
09/28/17Benzyl substituted indazoles as bub1 kinase inhibitors
09/28/17Benzyl substituted indazoles
09/28/17Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
09/21/17Substituted uracils as chymase inhibitors
09/14/17Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
09/14/17Substituted n,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents
09/14/17Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
09/14/173-nitrogen or sulphur substituted oestra-1,3,5(10),16-tetraene akr1c3 inhibitors
09/07/17Substituted pyridobenzodiazepinone-derivatives and use thereof
08/24/17(aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
08/24/17Amino-substituted annulated pyrimidines and use thereof
08/17/17Substituted quinoline-4-carboxamides and use thereof
08/17/17Substituted quinoline-4-carboxamides and use thereof
08/17/17Substituted annulated pyrimidines and use thereof
08/10/17Laminate changing device
08/10/17Glucose transport inhibitors
08/10/17Fluorinated benzofuranyl-pyrimidine derivatives containing a suflone group
08/03/172-(morpholin-4-yl)-1,7-naphthyridines
08/03/17Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
08/03/17Amino-substituted isoxazoles
08/03/17Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
08/03/17Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient
07/27/17Glucose transport inhibitors
07/20/175-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
07/20/17Polyethylene glycol based prodrug of adrenomedullin and use thereof
07/13/17Benzimidazol-2-amines as midh1 inhibitors
07/13/17Benzimidazol-2-amines as midh1 inhibitors
07/13/17Benzothiadiazolamines
06/29/17Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/25/17Cyclic thienouracil-carboxamides and use thereof
05/25/17Method for targeted conjugation of peptides and proteins by paired c2 bridging of cysteine amino acids
05/04/17Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
05/04/17Heterobicyclically substituted 4-oxobutane acid derivatives and use thereof
05/04/17Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups
04/27/172,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases
04/27/17Inhibitors of the wnt signalling pathways
04/20/17Novel compounds
04/20/17Substituted tetrahydropyridothienopyrimidines
04/13/173-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
04/13/176-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators
03/23/17Phenyl and benzodioxinyl substituted indazoles derivatives
03/02/17Substituted imidazo[1,2-a]pyridinecarboxamides and their use
03/02/17Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
02/23/17Imidazo[1,2-a]pyridines as soluble guanylate cyclase stimulators for the treatment of cardiovascular diseases
02/23/17Imidazo[1,2-a]pyridines as stimulators of soluble guanylate cyclase for treating cardiovascular diseases
02/09/17Substituted oxopyridine derivatives and use thereof as factor xia/plasma
02/09/17Glucose transport inhibitors
02/02/17Novel macrocyclic compounds
02/02/17Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
01/26/17Bicyclically substituted uracils and the use thereof
01/26/17Bicyclically substituted uracils and the use thereof
01/26/17Amido-substituted azole compounds
01/26/172,5-disubstituted cyclopentanecarboxylic acids and their use
01/19/17Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
01/12/17Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
01/05/175-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
12/22/16Polyethylene glycol based prodrug of adrenomedullin and use thereof
12/22/16Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
Patent Packs
12/15/16Aryl- and hetaryl-substituted imidazo[1,2-a]pyridine-3-carboxamides and use thereof
12/01/16Antibody drug conjugates (adcs) with kinesin spindel protein (ksp)
12/01/163-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
11/10/16Determination of a time-dependent contrast agent injection curve as a function of ct scan parameters
11/10/16Heteroaryl substituted pyrazoles
11/03/16Determining the velocity of a fluid using an imaging method
11/03/16Substituted bipiperidinyl derivatives
11/03/16Substituted piperidinyl-tetrahydroquinolines
11/03/16Novel benzimidazole derivatives as ep4 ligands
10/27/16Adenosine a1 agonists as medicaments for kidney disorders
10/27/16Novel indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
10/20/16Combination of pi3k-inhibitors
10/20/16Combination of pi3k-inhibitors
10/20/16Substituted piperidinyltetrahydroquinolines
10/20/16Substituted bipiperidinyl derivatives
Patent Packs
10/13/16Progesterone receptor antagonist dosage form
10/13/16Substituted uracils and use thereof
10/13/16Substituted triazolopyridines
10/13/16Thienopyrimidines as mknk1 and mknk2 inhibitors
10/06/16Substituted-imidazopyridazines
10/06/16Substituted 1,2,4-triazine-3,5-diones and the use thereof as chymase inhibitors
10/06/162-(morpholin-4-yl)-1,7-naphthyridines
10/06/16Novel salts
09/29/16Substituted phenylalanine derivatives
09/29/16Substituted phenylalanine derivatives
09/22/16Substituted phenylalanine derivatives
09/22/16Substituted phenylalanine derivatives
09/22/16Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinases
09/22/16Substituted oxopyridine derivatives
09/15/16Novel compounds
09/15/16Substituted triazolopyridines having activity as mps-1 inhibitors
09/08/16Pharmaceutical dosage forms comprising sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-olate
09/01/16A novel stable formulation
08/25/16Substituted phenylalanine derivatives
08/25/16Substituted uracils as chymase inhibitors
08/25/16Substituted phenylalanine derivatives
08/25/16Cyclic thienouracil-carboxamides and use thereof
08/18/16Substituted phenylalanine derivatives
08/18/16Substituted phenylalanine derivatives
08/18/16Substituted phenylalanine derivatives
08/18/16Heterocyclic substituted trifluoromethyl pyrimidinones and their use
08/18/16Substituted phenylalanine derivatives
08/18/16Anti-tweakr antibodies and uses thereof
08/04/16Pharmaceutical compositions containing refametinib
08/04/16Disubstituted trifluoromethyl pyrimidinones and their use
Social Network Patent Pack
08/04/16Substituted phenylalanine derivatives
07/28/16Novel benzimidazole derivatives as ep4 antagonists
07/21/16Prodrug derivatives of substituted triazolopyridines
07/21/16Novel compounds for the treatment of cancer
07/07/16Bet-protein-inhibiting dihydropyridopyrazinones
06/30/16Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
06/23/16Combination of a imidazopyridazine derivative and a mitotic agent for the treatment of cancer
06/23/16Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones
06/23/16Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereof
06/16/16Heteroaryl substituted pyrazoles
Patent Packs
06/09/16Substituted pyrazolopyridines
06/09/16Substituted thienopyrimidines and pharmaceutical use thereof
06/02/16Substituted benzylpyrazoles
06/02/16Substituted oxopyridine derivatives and use thereof as factor xia/plasma
05/26/16Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
05/26/16Heteroaryl substituted pyrazoles
05/26/16Diaminoheteroaryl substituted pyrazoles
05/26/16Heteroaryl substituted pyrazoles
05/19/16Substituted benzoxazoles
05/12/16Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
05/12/16Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
05/05/163-aryl-substituted imidazo[1,2-a]pyridines and their use
05/05/16Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
05/05/163-aryl-substituted imidazo[1,2-a]pyridines and their use
04/21/16Substituted benzoxazoles
04/21/16Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic diseases
04/07/16Mrg receptor modulators
03/31/16Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
03/31/16Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
03/03/16Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treating lymphomas
02/25/16Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
02/25/16Novel compounds
02/25/16Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists
02/18/16Use of (rs)-s-cyclopropyl-s-(4--5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treatment of specific tumours
02/18/16Heteroaryl substituted indazoles
02/18/163-heteroaryl substituted indazoles
01/28/16Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (akr1 c3)
01/21/16Substituted imidazopyridazines
01/14/16Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
01/14/16Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
Patent Packs
01/14/16Substituted thiazolopyrimidines
01/14/16Pdgfrbeta-fc fusion proteins and uses thereof
01/07/16Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
01/07/16Substituted pyrazolopyrimidinylamino-indazoles
01/07/16Benzyl-substituted pyrazolopyridines and use thereof
12/31/15Amidoimidazopyridazines as mknk-1 kinase inhibitors
12/31/154-substituted pyrrolo- and pyrazolo-diazepines
12/24/15Amino-substituted isothiazoles
12/03/15Combination comprising radium-223 for the treatment of cancer
12/03/15Combination comprising radium-223 for the treatment of cancer
12/03/15Bet-protein-inhibiting dihydroxyquinoxalinones
11/26/15Formulation for bispecific t-cell engagers (bites)
11/26/15Formulation for bispecific t-cell engagers (bites)
11/26/15Lock for drug injection device
11/19/15Fusion polypeptides and uses thereof
11/05/15Patient reported outcome instruments for endometriosis
10/29/15Substituted pyrazolopyrimidines as akt kinase inhibitors
10/22/15Bet protein-inhibiting 5-aryl triazole azepines
10/15/15Aminoimidazopyridazines
10/15/155-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Social Network Patent Pack
10/15/154-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
10/01/155-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
10/01/15N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
10/01/15Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
10/01/15Substituted annulated triazines and use thereof
09/24/15Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients
09/17/154-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group
09/10/15Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseases
08/27/15Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors
08/27/15Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors
08/20/15Catheter with drug coating
08/06/15Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disorders
07/30/15Substituted triazolopyridines and their use as ttk inhibitors
07/30/153-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
07/23/15Combination of regorafenib and acetylsalicylic acid for treating cancer
07/23/152,3-benzodiazepines
07/09/15N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products
07/02/15Substituted piperidines
06/25/15Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
06/04/15N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase
Social Network Patent Pack
06/04/15Substituted benzothienopyrimidines
05/28/15Bicyclically substituted uracils and the use thereof
05/28/15Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
05/28/15Method for preparing substituted triazolopyridines
05/21/15Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer
05/14/15Bis azainositol heavy metal complexes for x-ray imaging
05/14/15Thienopyrimidines
05/14/15Substituted pyrrolopyrimidines
05/07/15Pharmaceutical administration forms comprising 5-chloro-n-(methyl)-2-thiophenecarboxamide
05/07/15(aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
04/30/15Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
04/16/15Substituted imidazopyridazines
04/09/15Antibodies capable of binding to the coagulation factor xi and/or its activated form factor xia and uses thereof
04/02/15Amino-substituted imidazopyridazines
03/19/15Substituted benzothienyl - pyrrolotriazines and uses thereof in the treatment cancer
03/19/15Phenyl and benzodioxinyl substituted indazoles derivatives
03/05/15Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy
02/19/15Tyrosine based linkers for the releasable connection of peptides
01/01/15Substituted phenylimidazopyrazoles and use thereof
01/01/15Substituted imidazopyrazines as akt kinase inhibitors
09/25/14Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
09/04/14Trifluoromethyl-substituted fused pyrimidines and their use
06/26/14Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/14Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/14Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
05/08/14Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
05/08/14Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
01/30/14Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
01/09/14Pharmaceutical administration forms comprising 5-chloro-n-(methyl)-2-thiophenecarboxamide
11/28/13Fused pyrimidines
Social Network Patent Pack
11/21/13Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
09/05/13Medical device for dispersing medicaments
03/28/13Branched 3-phenylpropionic acid derivatives and their use
01/03/13Substituted oxazolidinones and their use in the field of blood coagulation
12/13/1217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases
10/25/12Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
10/18/12Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/12Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
10/18/12Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
10/11/1217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases
10/04/12Substituted (heteroarylmethyl)thiohydantoins
09/20/12Compounds for binding and imaging amyloid plaques and their use
09/20/12(heteroarylmethyl) thiohydantoins as anticancer drugs
09/20/12Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/20/12Non-polar and polar leaving groups
09/13/1217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases
08/30/12Substituted piperidines
08/23/12Heteroaryl-substituted piperidines
08/16/12Drug delivery systems (wafer) for pediatric use
08/16/12Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
08/09/12Pellets formulation
07/26/12Radiolabelling method using cycloalkyl groups
07/26/12Medication for oral administration, comprising at least one estrogen and/or at least one gestagen and at least one probiotic bacterial strain
07/26/12Anti-mesothelin immunoconjugates and uses therefor
07/26/1217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases
07/26/12Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
07/19/1217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases
07/19/12Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
07/05/12Pharmaceutical composition for emergency contraception







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bayer Pharma Aktiengesellschaft in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Pharma Aktiengesellschaft with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';